(PDF) P2.09-04 PD-L1 Expression in Primary Lung

P2.09-04 PD-L1 Expression in Primary Lung Adenocarcinoma and Its Relation With EGFR / KRAS Mutation and Clinicopathological Features

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1301

Full Text

Open PDF

Abstract

Available in full text

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

Multiple Primary Lung Cancers Containing Adenocarcinoma With EGFR Gene Mutation and Adenocarcinoma With Strong PD-L1 Positivity

Japanese Journal of Lung Cancer

English

Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status

PLoS ONE

Multidisciplinary

2013

English

KRAS Mutation-Induced Upregulation of PD-L1 Mediates Immune Escape in Human Lung Adenocarcinoma

Cancer Immunology, Immunotherapy

English

P010 Relationship Between EGFR and KRAS Mutation and the Clinicopathologic Features of Early Lung Adenocarcinoma

Journal of Thoracic Oncology

English

MicroRNA-155-5p Suppresses PD-L1 Expression in Lung Adenocarcinoma

English

ALK Fusion Protein Expression in Lung Adenocarcinoma and Its Correlation With EGFR Protein Expression

Madridge Journal of Oncogenesis

2018

English

MA15.01 Strong PD-L1 Expression Predicts Poor Response and De Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients With EGFR Mutation

Journal of Thoracic Oncology

English

Prognostic Value and Clinicopathological Features of PD-1/PD-L1 Expression With Mismatch Repair Status and Desmoplastic Stroma in Chinese Patients With Pancreatic Cancer

Oncotarget

Oncology

2016

English

CT Imaging-Based Histogram Features for Prediction of EGFR Mutation Status of Bone Metastases in Patients With Primary Lung Adenocarcinoma

Cancer Imaging

Nuclear Medicine

Radiology

Ultrasound Technology

English

Amanote Research

P2.09-04 PD-L1 Expression in Primary Lung Adenocarcinoma and Its Relation With EGFR / KRAS Mutation and Clinicopathological Features

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1301

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Multiple Primary Lung Cancers Containing Adenocarcinoma With EGFR Gene Mutation and Adenocarcinoma With Strong PD-L1 Positivity

Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status

KRAS Mutation-Induced Upregulation of PD-L1 Mediates Immune Escape in Human Lung Adenocarcinoma

P010 Relationship Between EGFR and KRAS Mutation and the Clinicopathologic Features of Early Lung Adenocarcinoma

MicroRNA-155-5p Suppresses PD-L1 Expression in Lung Adenocarcinoma

ALK Fusion Protein Expression in Lung Adenocarcinoma and Its Correlation With EGFR Protein Expression

MA15.01 Strong PD-L1 Expression Predicts Poor Response and De Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients With EGFR Mutation

Prognostic Value and Clinicopathological Features of PD-1/PD-L1 Expression With Mismatch Repair Status and Desmoplastic Stroma in Chinese Patients With Pancreatic Cancer

CT Imaging-Based Histogram Features for Prediction of EGFR Mutation Status of Bone Metastases in Patients With Primary Lung Adenocarcinoma